Search

Agnieszka Boesen

Examiner (ID: 10144, Phone: (571)272-8035 , Office: P/1648 )

Most Active Art Unit
1648
Art Unit(s)
1671, 1672, 1648
Total Applications
1050
Issued Applications
614
Pending Applications
117
Abandoned Applications
353

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5323472 [patent_doc_number] => 20090061462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Prion-specific peptide reagents' [patent_app_type] => utility [patent_app_number] => 12/079573 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 34655 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20090061462.pdf [firstpage_image] =>[orig_patent_app_number] => 12079573 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/079573
Prion-specific peptide reagents Mar 26, 2008 Abandoned
Array ( [id] => 4960567 [patent_doc_number] => 20080274992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'RECOMBINANT MODIFIED ANKARA VIRAL HIV-1 VACCINES' [patent_app_type] => utility [patent_app_number] => 12/055619 [patent_app_country] => US [patent_app_date] => 2008-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18609 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274992.pdf [firstpage_image] =>[orig_patent_app_number] => 12055619 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/055619
RECOMBINANT MODIFIED ANKARA VIRAL HIV-1 VACCINES Mar 25, 2008 Abandoned
Array ( [id] => 4719333 [patent_doc_number] => 20080241855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism' [patent_app_type] => utility [patent_app_number] => 12/076090 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17697 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241855.pdf [firstpage_image] =>[orig_patent_app_number] => 12076090 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/076090
Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism Mar 12, 2008 Issued
Array ( [id] => 6340616 [patent_doc_number] => 20100247618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'Novel synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV' [patent_app_type] => utility [patent_app_number] => 12/073887 [patent_app_country] => US [patent_app_date] => 2008-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22515 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247618.pdf [firstpage_image] =>[orig_patent_app_number] => 12073887 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/073887
Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV Mar 10, 2008 Issued
Array ( [id] => 4927890 [patent_doc_number] => 20080167253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'MONOCYTE LOCOMOTION INHIBITORY FACTOR' [patent_app_type] => utility [patent_app_number] => 12/040253 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8292 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167253.pdf [firstpage_image] =>[orig_patent_app_number] => 12040253 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/040253
Monocyte locomotion inhibitory factor Feb 28, 2008 Issued
Array ( [id] => 6639642 [patent_doc_number] => 20100227313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Methods and Compositions for Determining Altered Susceptibility of HIV-1 to Protease Inhibitor Treatment' [patent_app_type] => utility [patent_app_number] => 12/527861 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28913 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227313.pdf [firstpage_image] =>[orig_patent_app_number] => 12527861 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/527861
Methods and Compositions for Determining Altered Susceptibility of HIV-1 to Protease Inhibitor Treatment Feb 24, 2008 Abandoned
Array ( [id] => 4866253 [patent_doc_number] => 20080145312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Methods for rapid screening of mad cow disease and other transmissible spongiform encephalopathies' [patent_app_type] => utility [patent_app_number] => 12/032397 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2532 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145312.pdf [firstpage_image] =>[orig_patent_app_number] => 12032397 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/032397
Methods for rapid screening of mad cow disease and other transmissible spongiform encephalopathies Feb 14, 2008 Abandoned
Array ( [id] => 10115772 [patent_doc_number] => 09150643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Methods for treating diabetes' [patent_app_type] => utility [patent_app_number] => 12/070067 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 11931 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12070067 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/070067
Methods for treating diabetes Feb 13, 2008 Issued
Array ( [id] => 5507986 [patent_doc_number] => 20090081193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'HEMAGGLUTININ POLYPEPTIDES, AND REAGENTS AND METHODS RELATING THERETO' [patent_app_type] => utility [patent_app_number] => 11/969040 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 27586 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081193.pdf [firstpage_image] =>[orig_patent_app_number] => 11969040 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/969040
HEMAGGLUTININ POLYPEPTIDES, AND REAGENTS AND METHODS RELATING THERETO Jan 2, 2008 Abandoned
Array ( [id] => 4825802 [patent_doc_number] => 20080124793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'MEMBRANE FUSION PROTEINS DERIVED FROM REOVIRUS' [patent_app_type] => utility [patent_app_number] => 11/952714 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13682 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124793.pdf [firstpage_image] =>[orig_patent_app_number] => 11952714 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/952714
Membrane fusion proteins derived from reovirus Dec 6, 2007 Issued
Array ( [id] => 4859146 [patent_doc_number] => 20080267996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Compositions for inducing an immune response against hepatitis B' [patent_app_type] => utility [patent_app_number] => 11/986294 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19210 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267996.pdf [firstpage_image] =>[orig_patent_app_number] => 11986294 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/986294
Compositions for inducing an immune response against hepatitis B Nov 19, 2007 Abandoned
Array ( [id] => 8189603 [patent_doc_number] => 08183354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Virus coat protein/receptor chimeras and methods of use' [patent_app_type] => utility [patent_app_number] => 11/940445 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 19940 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183354.pdf [firstpage_image] =>[orig_patent_app_number] => 11940445 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/940445
Virus coat protein/receptor chimeras and methods of use Nov 14, 2007 Issued
Array ( [id] => 581119 [patent_doc_number] => 07449323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Hemorrhagic feline calicivirus' [patent_app_type] => utility [patent_app_number] => 11/939480 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8301 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449323.pdf [firstpage_image] =>[orig_patent_app_number] => 11939480 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/939480
Hemorrhagic feline calicivirus Nov 12, 2007 Issued
Array ( [id] => 4833367 [patent_doc_number] => 20080131914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'ASSESSING RISK OF CEREBROVASCULAR THROMBOSIS BY MEASURING C4D' [patent_app_type] => utility [patent_app_number] => 11/939188 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7625 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131914.pdf [firstpage_image] =>[orig_patent_app_number] => 11939188 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/939188
ASSESSING RISK OF CEREBROVASCULAR THROMBOSIS BY MEASURING C4D Nov 12, 2007 Abandoned
Array ( [id] => 24377 [patent_doc_number] => 07795417 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Oligonucleotides and methods for detection of west nile virus' [patent_app_type] => utility [patent_app_number] => 11/935668 [patent_app_country] => US [patent_app_date] => 2007-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 1 [patent_no_of_words] => 10779 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795417.pdf [firstpage_image] =>[orig_patent_app_number] => 11935668 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/935668
Oligonucleotides and methods for detection of west nile virus Nov 5, 2007 Issued
Array ( [id] => 11205381 [patent_doc_number] => 09435001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-06 [patent_title] => 'Detection method for cervical HPVS' [patent_app_type] => utility [patent_app_number] => 12/741018 [patent_app_country] => US [patent_app_date] => 2007-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7104 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 261 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12741018 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/741018
Detection method for cervical HPVS Oct 31, 2007 Issued
Array ( [id] => 5574978 [patent_doc_number] => 20090142339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Humanized Anti-CCR2 Antibodies and Methods of Use Therefor' [patent_app_type] => utility [patent_app_number] => 11/924783 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 33503 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142339.pdf [firstpage_image] =>[orig_patent_app_number] => 11924783 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/924783
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor Oct 25, 2007 Abandoned
Array ( [id] => 5434955 [patent_doc_number] => 20090169541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Humanized Anti-CCR2 Antibodies and Methods of Use Therefor' [patent_app_type] => utility [patent_app_number] => 11/925080 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 33503 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169541.pdf [firstpage_image] =>[orig_patent_app_number] => 11925080 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/925080
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor Oct 25, 2007 Abandoned
Array ( [id] => 266926 [patent_doc_number] => 07566450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-28 [patent_title] => 'Humanized anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 11/924794 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 64 [patent_no_of_words] => 33550 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566450.pdf [firstpage_image] =>[orig_patent_app_number] => 11924794 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/924794
Humanized anti-CCR2 antibodies and methods of use therefor Oct 25, 2007 Issued
Array ( [id] => 6562180 [patent_doc_number] => 20100272753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Recombinant Adenovirus Vaccines' [patent_app_type] => utility [patent_app_number] => 12/447357 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9073 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272753.pdf [firstpage_image] =>[orig_patent_app_number] => 12447357 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/447357
Recombinant Adenovirus Vaccines Oct 25, 2007 Abandoned
Menu